Compare Align Technology, Inc. (ALGN) vs Kimberly Clark Corp (KMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Align Technology, Inc. vs Kimberly Clark Corp — how do they compare? Align Technology, Inc. trades at $176.07 (market cap $12.36B), while Kimberly Clark Corp trades at $110.6 (market cap $36.23B). The key difference: Kimberly Clark Corp is far larger — about 2.9× Align Technology, Inc.'s market cap, and Kimberly Clark Corp pays a 4.7% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | KMB | |
|---|---|---|
Market Cap | $12.36B | $36.23B |
Sector | Health | Consumer Staples |
52-Week High | $197.51 | $134.81 |
52-Week Low | $124.88 | $93.05 |
Enterprise Value | $11.38B | $41.79B |
Dividend Yield | — | 4.7% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALGN trades at $176.20, up 1.88% today, with a bearish technical signal but strong fundamentals including a 68.05% gross margin and three consecutive quarterly earnings beats. Recent news highlights a patent win in China and strategic board changes following activist engagement, while cash flow trends show improving net cash generation from $51M in 2025 to a projected $202M in 2026.
The stock offers value with a P/E of 30.21 near five-year lows, supported by 72.73% analyst buy ratings, but faces risks from scanner segment pressure and North American growth stagnation. Upside hinges on international expansion and digital platform execution amid competitive and macroeconomic headwinds.
Kimberly-Clark (KMB) trades at $110.70, up 1.96% today, near the consensus price target of $113.20. The stock shows mixed signals with a neutral technical outlook and strong profitability (ROE 129.43%, net margin 11.79%), though Q2 2026 earnings missed estimates. Recent news highlights leadership changes and institutional buying, but China market headwinds and lowered 2026 guidance pose challenges.
KMB offers a stable dividend yield and solid cash flow, but near-term growth is pressured by regional softness and integration risks from the Kenvue acquisition. Analyst sentiment is cautious with 61% hold ratings. The stock presents value for income investors, yet requires monitoring of sales recovery and margin sustainability amid macroeconomic uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Kimberly Clark Corp
With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →
